The effect of montelukast in treatment of Pollakiuria
Phase 2
Recruiting
- Conditions
- R35.0Pollakiuria (The daytime urinary frequency syndrome).Frequency of micturition
- Registration Number
- IRCT20210626051718N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
All children with pollakiuria aged 3-18 years referred to the pediatric clinic of Amirkabir Hospital in Arak
Children with pollakiuria aged 3-18 years who were hospitalized in the pediatric wards of Amirkabir Hospital in Arak
History of allergy
Exclusion Criteria
Allergiy history to Montelukast
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of daytime urination. Timepoint: First at the beginning of the study and then after 14days of receiving treatment. Method of measurement: After 14 days of treatment,the frequency of daytime urination and the exact day which the symptoms had improved will be asked from mothers.Then these information will be noted in check list.
- Secondary Outcome Measures
Name Time Method